GO:0045986 negative regulation of smooth muscle contraction: Smooth Muscle Relaxation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045986 describes any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction, and is synonymous with smooth muscle relaxation.
• Negative regulation of smooth muscle contraction is driven mainly by lowering cytosolic Ca2+ and by reducing Ca2+ sensitivity of the contractile apparatus.
• Excitation-contraction coupling in smooth muscle is under negative-feedback control, so inhibitory signaling is built into the same pathway that triggers contraction.
• Key molecular players include BK channels, RyR channels, TRPC channels, G-alpha proteins, FOXO3, and miR-342-5p, which tune vascular and visceral smooth muscle tone.
• Loss of negative regulation contributes to labor onset disorders, lower urinary tract dysfunction, and vascular phenotypic transition, making this GO term clinically relevant.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the main tools for testing causality of candidate genes in this process.
Description
GO:0045986, negative regulation of smooth muscle contraction, is a biological process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction, and is commonly referred to as smooth muscle relaxation. Smooth muscle contraction is initiated when a rise in cytosolic calcium activates calcium-calmodulin-dependent myosin light chain kinase, and negative regulation reverses or prevents this activation. Because smooth muscle controls the diameter of blood vessels, airways, the gastrointestinal tract, and the urogenital system, the ability to relax these tissues is as important as the ability to contract them. Researchers study GO:0045986 to understand how tissues avoid excessive or premature contraction, and how this balance is lost in disease. The process is not simply the absence of contraction; it is an active, regulated set of signaling events that includes calcium sequestration, inhibition of calcium entry, activation of potassium channels, and modulation of calcium sensitization. Recent work has linked negative regulation of smooth muscle contraction to microRNAs, macrophage-derived signals, and ion channel coupling, showing that the term sits at the intersection of vascular biology, reproductive physiology, and urology.
negative regulation of smooth muscle contraction At A Glance
| GO ID | GO:0045986 |
|---|---|
| GO term | negative regulation of smooth muscle contraction |
| Ontology | biological_process |
| Synonym | smooth muscle relaxation; inhibition of smooth muscle contraction; downregulation of smooth muscle contraction |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction |
| Key ions | Calcium (Ca2+) and potassium (K+) |
| Key channels | BK channels, RyR channels, TRPC channels |
| Key signaling | G-alpha proteins, Notch signaling, FOXO3, miR-342-5p |
| Related disease areas | Labor onset, lower urinary tract dysfunction, vascular remodeling |
What Is GO:0045986?
In your own words, GO:0045986 is the collection of cellular processes that reduce, prevent, or stop smooth muscle contraction. It includes signals that lower intracellular calcium, close or inhibit calcium-permeable channels, open potassium channels to hyperpolarize the membrane, and reduce the sensitivity of the contractile machinery to calcium. It is the functional opposite of positive regulation of smooth muscle contraction and is often described as smooth muscle relaxation.
Why Is negative regulation of smooth muscle contraction Important in Cell Biology?
Negative regulation of smooth muscle contraction is essential for normal physiology because it allows hollow organs and blood vessels to relax after contraction, maintaining blood flow, urine storage, airway patency, and timely labor. When this process fails, smooth muscle remains contracted, contributing to hypertension, bronchoconstriction, urinary retention, and preterm or delayed labor. The term is also important for drug discovery because calcium-channel blockers and other relaxants act by enhancing negative regulation of smooth muscle contraction. Understanding the molecular players in GO:0045986 helps researchers identify therapeutic targets and design experiments that test causality.
• Maintains blood vessel diameter and tissue perfusion by relaxing vascular smooth muscle.
• Controls urine storage and voiding through BK-RyR coupling in the lower urinary tract.
• Regulates labor onset via macrophage-derived signals acting on uterine smooth muscle.
• Prevents excessive contraction in the gastrointestinal tract through negative-feedback control.
• Provides the mechanistic basis for calcium-channel blocker action.
• Involves microRNAs such as miR-342-5p that tune vascular smooth muscle phenotype.
• Depends on ion channels such as TRPC channels modulated by G-alpha proteins.
• Is a target for CRISPR-based functional studies of candidate genes.
• Links to disease when negative regulation is lost, causing hypercontractile states.
• Offers a clear readout for drug screening and bioinformatics analysis.
What Happens During negative regulation of smooth muscle contraction?
Reduction of cytosolic calcium
In simple terms: The cell lowers the calcium level that would otherwise trigger contraction.
Smooth muscle contraction depends on a rise in cytosolic calcium, which activates myosin light chain kinase. Negative regulation begins when calcium is removed from the cytosol by sequestration into the sarcoplasmic reticulum or extrusion across the plasma membrane. Calcium-channel blocking agents reduce calcium entry and thereby promote relaxation, illustrating that lowering calcium is a primary mechanism of negative regulation. In gastric smooth muscle, negative-feedback regulation of excitation-contraction coupling helps terminate calcium signals after stimulation.
Inhibition of calcium entry channels
In simple terms: The cell closes the doors that let calcium in.
Calcium entry through plasma membrane channels sustains contraction, so inhibiting these channels is a direct way to negatively regulate contraction. TRPC ion channels are directly modulated by G-alpha proteins, providing a mechanism by which G-protein-coupled receptors can reduce calcium influx. Calcium-channel blocking agents such as those reviewed by Leonard and colleagues act on voltage-dependent calcium channels to reduce calcium entry and relax smooth muscle.
Activation of potassium channels and hyperpolarization
In simple terms: Opening potassium channels makes the cell less excitable, so it relaxes.
BK channels are large-conductance calcium-activated potassium channels that, when opened, hyperpolarize the membrane and reduce calcium entry through voltage-dependent channels. BK-RyR coupling in the lower urinary tract is a well-described mechanism for negative regulation of smooth muscle contraction, where ryanodine receptor-mediated calcium sparks activate BK channels to promote relaxation. This coupling is important in both physiology and pathophysiology of the lower urinary tract.
Negative-feedback control of excitation-contraction coupling
In simple terms: The contraction pathway contains its own brakes.
Excitation-contraction coupling in smooth muscle is subject to negative-feedback regulation, meaning that activation of the pathway triggers signals that limit its own activity. Ozaki and colleagues demonstrated this in gastric smooth muscle, showing that negative-feedback regulation helps prevent excessive or prolonged contraction. This built-in braking system is a core feature of GO:0045986 and explains why smooth muscle tone is dynamic rather than all-or-none.
Modulation by microRNAs and transcriptional regulators
In simple terms: Small RNA molecules and transcription factors can dial down contraction.
miR-342-5p promotes vascular smooth muscle cell phenotypic transition through a negative-feedback regulation of Notch signaling via targeting FOXO3. This illustrates that negative regulation of smooth muscle contraction can be controlled at the level of gene expression by microRNAs and transcription factors. Such mechanisms allow long-term changes in smooth muscle contractile phenotype, distinct from rapid calcium-dependent relaxation.
Immune and macrophage-derived signals
In simple terms: Immune cells can send signals that change how smooth muscle contracts.
M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset. This finding shows that negative regulation of smooth muscle contraction in the uterus is influenced by immune cell populations and their death pathways. It expands the concept of GO:0045986 beyond intrinsic smooth muscle signaling to include paracrine control by macrophages.
Key Genes Involved in GO:0045986 negative regulation of smooth muscle contraction
The following genes and proteins have been experimentally linked to negative regulation of smooth muscle contraction or to the signaling pathways that control it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FOXO3 | Transcription factor targeted by miR-342-5p in vascular smooth muscle | Controls phenotypic transition and Notch signaling |
| Notch signaling components | Negative-feedback regulation of vascular smooth muscle phenotype | Modulated by miR-342-5p via FOXO3 |
| miR-342-5p | MicroRNA that targets FOXO3 and tunes Notch signaling | Promotes vascular smooth muscle cell phenotypic transition |
| BK channels (KCNMA1) | Calcium-activated potassium channels that hyperpolarize smooth muscle | Central to BK-RyR coupling in lower urinary tract |
| RyR channels (RYR1/RYR2/RYR3) | Ryanodine receptors that generate calcium sparks | Couple to BK channels to promote relaxation |
| TRPC channels | Calcium-permeable channels modulated by G-alpha proteins | Direct modulation by G-alpha proteins affects contraction |
| G-alpha proteins | Signal transducers that modulate TRPC channels | Direct modulation of TRPC ion channels |
| Myosin light chain kinase (MYLK) | Phosphorylates myosin light chain to initiate contraction | Its inhibition is a mechanism of negative regulation |
| Myosin light chain phosphatase (PPP1R12A) | Dephosphorylates myosin light chain to promote relaxation | Opposes contraction and supports negative regulation |
| Calmodulin (CALM1/2/3) | Calcium sensor that activates MYLK | Reducing calcium-calmodulin signaling promotes relaxation |
| Voltage-dependent calcium channels | Mediate calcium entry for contraction | Blocked by calcium-channel blocking agents |
| M2 macrophage markers | Immune cells that regulate uterine smooth muscle | Ferroptosis of M2 macrophages facilitates labor onset |
| Ferroptosis-related genes | Cell death pathway in macrophages | Linked to uterine smooth muscle contraction regulation |
| Calcium ATPases (SERCA, PMCA) | Remove calcium from cytosol | Support calcium lowering and relaxation |
| RhoA/Rho-kinase pathway | Calcium sensitization machinery | Modulates contractile apparatus sensitivity |
| Nitric oxide synthase (NOS) | Produces nitric oxide to relax smooth muscle | Classic relaxant pathway in vascular and visceral smooth muscle |
| cGMP-dependent protein kinase (PRKG1) | Mediates nitric oxide-induced relaxation | Reduces calcium sensitivity and promotes relaxation |
How Is negative regulation of smooth muscle contraction Regulated?
Negative regulation of smooth muscle contraction is itself regulated at multiple levels. Acute regulation occurs through calcium removal, inhibition of calcium entry, and opening of potassium channels such as BK channels. G-protein-coupled receptor signaling can directly modulate TRPC channels via G-alpha proteins, providing a fast inhibitory input. Negative-feedback loops within excitation-contraction coupling limit the duration of contraction. Longer-term regulation involves microRNAs such as miR-342-5p, which targets FOXO3 and modulates Notch signaling to control vascular smooth muscle phenotype. Immune-derived signals, including those from M2 macrophages undergoing ferroptosis, can regulate uterine smooth muscle contraction during labor onset. Calcium-channel blocking agents act as pharmacological regulators by reducing calcium entry.
negative regulation of smooth muscle contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOXO3 | Vascular smooth muscle phenotypic transition | Knockout or overexpression in vascular smooth muscle cells |
| miR-342-5p | Vascular remodeling | Mimic or inhibitor treatment in smooth muscle cells |
| BK channels (KCNMA1) | Lower urinary tract dysfunction | Knockout mouse or point-mutation models |
| RyR channels | Lower urinary tract dysfunction | Knock-in or knockout in urological tissue |
| M2 macrophage ferroptosis genes | Labor onset disorders | Macrophage-specific knockout or overexpression |
Vascular smooth muscle phenotypic transition and vascular disease
miR-342-5p promotes vascular smooth muscle cell phenotypic transition through negative-feedback regulation of Notch signaling via targeting FOXO3. This suggests that dysregulation of negative regulation of smooth muscle contraction contributes to vascular remodeling and diseases characterized by altered smooth muscle phenotype. Researchers can model this by manipulating miR-342-5p or FOXO3 in vascular smooth muscle cells.
Labor onset and uterine smooth muscle disorders
M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset. This links negative regulation of smooth muscle contraction to the timing of labor and suggests that immune cell death pathways can influence uterine contractility. Experimental models can test whether macrophage ferroptosis genes alter uterine smooth muscle contraction.
Lower urinary tract dysfunction
BK-RyR coupling in the lower urinary tract is important in physiology and pathophysiology, and disruption of this coupling can lead to urinary tract dysfunction. Because BK channel activation promotes relaxation, loss of this negative regulation can cause hypercontractile states. This provides a rationale for studying BK and RyR genes in urological disease models.
Hypertension and bronchoconstriction
Calcium-channel blocking agents are used clinically to relax vascular and other smooth muscle by reducing calcium entry. This demonstrates that enhancing negative regulation of smooth muscle contraction is a validated therapeutic strategy for hypertension and related disorders. Understanding the underlying calcium and potassium mechanisms can guide development of new relaxants.
From negative regulation of smooth muscle contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FOXO3 mediate miR-342-5p effects on vascular smooth muscle phenotype? | FOXO3 knockout and overexpression in vascular smooth muscle cells |
| Does BK channel opening promote relaxation in the lower urinary tract? | BK channel knockout or point-mutation mouse |
| Do macrophage ferroptosis genes regulate uterine contraction? | Macrophage-specific knockout or knock-in models |
| Does TRPC modulation by G-alpha proteins affect contraction? | TRPC knockout or point-mutation cells |
| Does miR-342-5p targeting of FOXO3 require Notch signaling? | Notch reporter knock-in and miR-342-5p overexpression |
| Can calcium-channel blockade be modeled genetically? | Voltage-dependent calcium channel knockout or point mutation |
How to Study the negative regulation of smooth muscle contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium concentration | Testing calcium lowering during relaxation |
| Patch-clamp electrophysiology | Ion channel currents and membrane potential | BK and TRPC channel function |
| Contractility assay | Force generation in smooth muscle | Testing relaxation in tissue strips |
| RNA sequencing | Gene expression changes | Identifying pathways in phenotypic transition |
| Western blot | Protein expression and phosphorylation | Measuring myosin light chain phosphorylation |
| Immunofluorescence | Protein localization in tissue | Studying BK-RyR coupling |
| CRISPR screening | Gene function at scale | Identifying regulators of smooth muscle contraction |
| Bioinformatics pathway analysis | Enriched signaling pathways | Linking miR-342-5p to Notch and FOXO3 |
Calcium imaging
Calcium imaging measures changes in intracellular calcium that underlie smooth muscle contraction and relaxation. It is used to test whether a candidate gene alters calcium handling during negative regulation of smooth muscle contraction. This method is typically applied to isolated smooth muscle cells or tissue explants.
Patch-clamp electrophysiology
Patch-clamp electrophysiology measures ion channel activity, including BK and TRPC channel currents. It is used to determine whether a gene manipulation changes channel opening or membrane potential. This method is applied to study BK-RyR coupling and G-alpha modulation of TRPC channels.
Contractility assays
Contractility assays measure force generation in smooth muscle strips or gels. They are used to test whether genetic or pharmacological interventions enhance or reduce contraction. This method is applied to gastric, vascular, uterine, and lower urinary tract smooth muscle.
RNA sequencing and bioinformatics
RNA sequencing measures changes in gene expression after manipulation of candidate genes. Bioinformatics analysis identifies pathways such as Notch signaling and FOXO3 targets that contribute to negative regulation of smooth muscle contraction. This method is applied to vascular smooth muscle phenotypic transition studies.
How CRISPR Can Be Used to Study GO:0045986 negative regulation of smooth muscle contraction
Knockout
CRISPR knockout is used to delete candidate genes such as FOXO3, BK channels, or TRPC channels to test whether they are required for negative regulation of smooth muscle contraction. Knockout models can reveal loss-of-relaxation phenotypes in vascular, urinary, or uterine smooth muscle. This approach is foundational for establishing causality in GO:0045986 research.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to test domain function, for example in BK channel calcium-sensing domains or TRPC channel gating residues. Point-mutation models help distinguish channel gating effects from expression effects. They are useful when a disease-associated variant is suspected to alter negative regulation of smooth muscle contraction.
Knock-in
CRISPR knock-in can add tags, reporters, or disease-relevant alleles to study negative regulation of smooth muscle contraction in live cells. For example, a Notch reporter knock-in can monitor signaling changes driven by miR-342-5p. Knock-in models are also used to express mutant BK or RyR channels at physiological levels.
Overexpression
CRISPR overexpression, often via safe-harbor insertion, is used to increase levels of relaxant genes or microRNAs such as miR-342-5p. Overexpression can test whether a candidate gene is sufficient to promote relaxation or phenotypic transition. This complements knockout studies by providing gain-of-function evidence.
How EDITGENE Supports negative regulation of smooth muscle contraction Research
Researchers studying negative regulation of smooth muscle contraction-related genes often need to determine whether a candidate gene is causally involved in relaxation or contraction, rather than merely correlated with it. EDITGENE provides CRISPR-based cell models and screening services that allow precise manipulation of genes such as FOXO3, BK channels, TRPC channels, and macrophage ferroptosis regulators in relevant smooth muscle and immune cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of smooth muscle contraction research.
Frequently Asked Questions About negative regulation of smooth muscle contraction
What is GO:0045986 negative regulation of smooth muscle contraction?
GO:0045986 is a biological process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction, commonly called smooth muscle relaxation.
What genes are involved in negative regulation of smooth muscle contraction?
Genes and proteins include FOXO3, Notch signaling components, miR-342-5p, BK channels, RyR channels, TRPC channels, G-alpha proteins, myosin light chain kinase, and myosin light chain phosphatase.
How does calcium affect smooth muscle relaxation?
Lowering cytosolic calcium removes the signal needed for myosin light chain kinase activation, thereby promoting relaxation.
What role do BK channels play in smooth muscle relaxation?
BK channels open in response to calcium sparks from RyR channels, hyperpolarizing the membrane and reducing calcium entry, which promotes relaxation.
How do G-alpha proteins regulate smooth muscle contraction?
G-alpha proteins directly modulate TRPC ion channels, which can alter calcium entry and affect contraction.
What is the role of miR-342-5p in vascular smooth muscle?
miR-342-5p promotes vascular smooth muscle cell phenotypic transition through negative-feedback regulation of Notch signaling via targeting FOXO3.
Can macrophages regulate uterine smooth muscle contraction?
Yes, M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset.
What experimental models are used to study negative regulation of smooth muscle contraction?
Models include CRISPR knockout, point-mutation, knock-in, and overexpression cells, as well as calcium imaging, patch-clamp, and contractility assays.
Why is negative regulation of smooth muscle contraction important in disease?
Loss of negative regulation can lead to hypercontractile states such as lower urinary tract dysfunction, vascular remodeling, and abnormal labor onset.
How do calcium-channel blockers relate to this process?
Calcium-channel blocking agents reduce calcium entry and thereby enhance negative regulation of smooth muscle contraction, producing relaxation.
Conclusion
GO:0045986 negative regulation of smooth muscle contraction is an active, multi-layered biological process that lowers calcium, inhibits calcium entry, opens potassium channels, and modulates gene expression to relax smooth muscle. Its dysregulation is linked to vascular, urological, and reproductive disorders, making it a key area for mechanistic and therapeutic research. CRISPR-based models and functional assays provide the tools needed to test causality of candidate genes in this pathway.
References
- 1. Wen T et al.. 2023. miR-342-5p promotes vascular smooth muscle cell phenotypic transition through a negative-feedback regulation of Notch signaling via targeting FOXO3.. Life Sci 326:121828 PMID: 37270171
- 3. Ozaki H et al.. 1992. Negative-feedback regulation of excitation-contraction coupling in gastric smooth muscle.. Am J Physiol 263(6 Pt 1):C1160-71 PMID: 1476162
- 4. Jiang H et al.. 1994. Calcium and smooth muscle contraction.. Mol Cell Biochem 135(1):1-9 PMID: 7816050
- 5. Song L et al.. 2025. M2 macrophages undergoing ferroptosis regulate uterine smooth muscle contraction to facilitate labor onset.. Sci Rep 15(1):45152 PMID: 41429871
- 6. Ridlon M et al.. 2025. Smooth muscle of the lower urinary tract: BK-RyR coupling in physiology and pathophysiology.. J Muscle Res Cell Motil 46(4):487-505 PMID: 40889018
- 7. Kang H et al.. 2024. Direct modulation of TRPC ion channels by Gα proteins.. Front Physiol 15:1362987 PMID: 38384797
- 8. Leonard RG et al.. 1982. Calcium-channel blocking agents.. Clin Pharm 1(1):17-33 PMID: 6764159
